6505--Metolazone Tablets (VA-26-00032237)

The solicitation requires offerors to submit a detailed, VA‑approved subcontracting plan in accordance with FAR 52.219‑9 and VAAR 852.219‑70 for contracts exceeding $900,000. The plan must include separate dollar and percentage goals for each contract option period, justify any goal that is lower than the VA‑suggested or prior‑year achieved level, and specify whether indirect costs are included. Offerors must document the methods used to identify potential small‑business sources (e.g., specific websites, associations, events) and describe internal and external good‑faith efforts to provide equitable opportunities to small‑business, HUBZone, service‑disabled veteran‑owned, women‑owned, and other designated concerns. A current commercial plan (company‑wide or division‑wide) or a new plan must be submitted, along with the name, address, and role of the manufacturer (or distributor) for each covered drug product/NDC, confirming compliance with cGMP and inclusion on the offeror’s FSS contract or interim agreement. In addition, the offeror must designate a program administrator responsible for overseeing the subcontracting program and timely eSRS reporting, and must report quarterly sales and cost‑recovery fees as specified. All required provisions can be accessed via the FAR and VAAR links provided, and any unanswered provisions may be identified by paragraph number in the offer. Failure to meet the subcontracting, manufacturing, or reporting requirements will result in rejection of the offer.

Notice ID

f3ebb9296a01482ab1304b5143e514cc

Solicitation Number

36E79726R0016

NAICS Code

325412

Classification Code

6505